Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v8-EN
Language English English
Date Updated 2020-04-29 2020-01-20
Drug Identification Number 02351110 02351110
Brand name FAMOTIDINE TABLETS FAMOTIDINE TABLETS
Common or Proper name FAMOTIDINE FAMOTIDINE
Company Name SANIS HEALTH INC SANIS HEALTH INC
Ingredients FAMOTIDINE FAMOTIDINE
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-12-10 2019-12-10
Actual start date 2020-01-20 2020-01-20
Estimated end date 2020-04-30 2020-04-30
Actual end date 2020-04-28
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments